Skip to main content
. Author manuscript; available in PMC: 2014 Apr 25.
Published in final edited form as: Cancer Cell. 2012 Jan 17;21(1):66–81. doi: 10.1016/j.ccr.2011.11.024

Figure 8. Poor pericyte coverage and high Met expression is correlated with decreased survival of breast cancer patients.

Figure 8

(A) Disease-free and (B) overall survival of invasive ductal carcinoma (IDC) patients with relation to CD31+ vessel-associated NG2 expression together with Met expression. (C) Baseline demographics and clinical characteristics associated with CD31+ vessel-associated NG2 expression and Met expression.